The CRISPR patents are back in play. The pair shared a 2020 Nobel Prize for developing the gene-editing system, which is already being used to treat various disorders. —Antonio RegaladoTo read more about CRISPR, why not take a look at:+ Charpentier and Doudna announced they wanted to cancel their own CRISPR patents in Europe last year. + The US has approved CRISPR pigs for food. + CRISPR will get easier and easier to administer.